KillerRed protein based in vivo photodynamic therapy and corresponding tumor metabolic imaging

Qiaoya Lin; Shuang Sha; Fei Yang; Honglin Jin; Zhihong Zhang

doi:10.1142/s1793545816400010

[1] M. A. Biel, "Photodynamic therapy and the treatment of head and neck neoplasia," The Laryngoscope 108, 1259–1268 (1998).

[2] M. A. Rosenthal, B. Kavar, J. S. Hill, D. J. Morgan, R. L. Nation, S. S. Stylli, R. L. Basser, S. Uren, H. Geldard,M.D. Green, S. B. Kahl, A.H. Kaye, "Phase I and pharmacokinetic study of photodynamic therapy for high-grade gliomas using a novel boronated porphyrin," J. Clin. Oncol. 19, 519–524 (2001).

[3] A. Dimofte, T. C. Zhu, S. M. Hahn, R. A. Lustig, "In vivo light dosimetry for motexafin lutetiummediated PDT of recurrent breast cancer," Lasers Surg. Med. 31, 305–312 (2002).

[4] D. E. Dolmans, D. Fukumura, R. K. Jain, "Photodynamic therapy for cancer," Nat. Rev. Cancer 3, 380–387 (2003).

[5] M. V. Shirmanova, E. O. Serebrovskaya, K. A. Lukyanov, L. B. Snopova, M. A. Sirotkina, N. N. Prodanetz, M. L. Bugrova, E. A. Minakova, I. V. Turchin, V. A. Kamensky, S. A. Lukyanov, E. V. Zagaynova, "Phototoxic effects of fluorescent protein KillerRed on tumor cells in mice," J. Biophotonics 6, 283–290 (2013).

[6] K. M. S. Russell, B. Vegh, Marina K. Kuimova, "Reactive oxygen species in photochemistry of the red fluorescent protein"Killer Red," Chem. Commun. 4, 4887–4889 (2011).

[7] V. Adler, Z. Yin, K. D. Tew, Z. Ronai, "Role of redox potential and reactive oxygen species in stress signaling," Oncogene 18, 6104–6111 (1999).

[8] V. Irihimovitch, M. Shapira, "Glutathione redox potential modulated by reactive oxygen species regulates translation of Rubisco large subunit in the chloroplast," J. Biol. Chem. 275, 16289–16295 (2000).

[9] Y. Ye, L. X. Wang, D. P. Zhang, Y. J. Yan, Z. L. Chen, "Studies on photodynamic mechanism of a novel chlorine derivative (TDPC) and its antitumor effect for photodynamic therapy in vitro and in vivo," J. Innov. Opt. Health. Sci. 8, (2015).

[10] R. W. K. Wu, E. S. M. Chu, Z. Huang, M. C. Olivo, D. C. W. Ip, C. M. N. Yow, "An in vitro investigation of photodynamic efficacy of FosPeg (R) on human colon cancer cells," J. Innov. Opt. Health. Sci. 8, (2015).

[11] Z. X. Liao, Y. C. Li, H. M. Lu, H. W. Sung, "A genetically-encoded KillerRed protein as an intrinsically generated photosensitizer for photodynamic therapy," Biomaterials 35, 500–508 (2014).

[12] G. Mueller, "From green to red — To more dead Autofluorescent proteins as photosensitizers," J. Photoch. Photobio. B 9, 95–98 (2010).

[13] M. E. Bulina, K. A. Lukyanov, O. V. Britanova, D. Onichtchouk, S. Lukyanov, D. M. Chudakov, "Chromophore-assisted light inactivation (CALI) using the phototoxic fluorescent protein KillerRed," Nat. Protoc. 1, 947–953 (2006).

[14] M. E. Bulina, D. M. Chudakov, O. V. Britanova, Y. G. Yanushevich, D. B. Staroverov, T. V. Chepurnykh, E. M. Merzlyak, M. A. Shkrob, S. Lukyanov, K. A. Lukyanov, "A genetically encoded photosensitizer," Nat. Biotechnol. 24, 95–99 (2006).

[15] E. O. Serebrovskaya, E. F. Edelweiss, O. A. Stremovskiy, K. A. Lukyanov, D. M. Chudakov, S. M. Deyev, "Targeting cancer cells by using an antireceptor antibody-photosensitizer fusion protein," Proc. Natl. Acad. Sci. USA 106, 9221–9225 (2009).

[16] W. Waldeck, G. Mueller, M. Wiessler, K. Toth, K. Braun, "Positioning effects of KillerRed inside of cells correlate with DNA strand breaks after activation with visible light," Int. J. Med. Sci. 8, 97–105 (2011).

[17] T. Shibuya, Y. Tsujimoto, "Deleterious effects of mitochondrial ROS generated by KillerRed photodynamic action in human cell lines and C. elegans," J. Photoch. Photobio. 117, 1–12 (2012).

[18] J. Morgan, A. R. Oseroff, "Mitochondria-based photodynamic anti-cancer therapy," Adv. Drug. Deliv. Rev. 49, 71–86 (2001).

[19] X. Wang, "The expanding role of mitochondria in apoptosis," Genes. Dev. 15, 2922–2933 (2001).

[20] S. Orrenius, "Mitochondrial regulation of apoptotic cell death," Toxicol. Lett. 149, 19–23 (2004).

[21] M. Ristow, "Oxidative metabolism in cancer growth," Curr. Opin. Clin. Nutr. 9, 339–345 (2006).

[22] L. Z. Li, "Imaging mitochondrial redox potential and its possible link to tumor metastatic potential," J. Bioenerg. Biomembr. 44, 645–653 (2012).

[23] J. W. Locasale, L. C. Cantley, "Metabolic flux and the regulation of mammalian cell growth," Cell Metab. 14, 443–451 (2011).

[24] P. P. Hsu, D. M. Sabatini, "Cancer cell metabolism: Warburg and beyond," Cell 134, 703–707 (2008).

[25] M. G. Vander Heiden, "Targeting cancer metabolism: A therapeutic window opens," Nat. Rev. Drug Discov. 10, 671–684 (2011).

[26] P. G. Michal Mokry, B. Vidinsky, "in vivo monitoring the changes of interstitial pH and FAD/ NADH," Photochem. Photobiol. 8, 793–797 (2006).

[27] Z. Zhang, H. Li, Q. Liu, L. Zhou, M. Zhang, Q. Luo, J. Glickson, B. Chance, G. Zheng, "Metabolic imaging of tumors using intrinsic and extrinsic fluorescent markers," Biosens. Bioelectron. 20, 643–650 (2004).

[28] B. Chance, B. Schoener, R. Oshino, F. Itshak, Y. Nakase, "Oxidation-reduction ratio studies of mitochondria in freeze-trapped samples. NADH and flavoprotein fluorescence signals," J. Biol. Chem. 254, 4764–4771 (1979).

[29] L. Z. Li, R. Zhou, H. N. Xu, L. Moon, T. Zhong, E. J. Kim, H. Qiao, R. Reddy, D. Leeper, B. Chance, J. D. Glickson, "Quantitative magnetic resonance and optical imaging biomarkers of melanoma metastatic potential," Proc. Natl. Acad. Sci. USA 106, 6608–6613 (2009).

[30] K. P. Q. Irene Georgakoudi, "Optical imaging using endogenous contrast to assess metabolic state," Annu. Rev. Biomed. Eng. 14, 351–367 (2012).

[31] D. B. Zhihong Zhang, Hui Li, "Redox ratio of mitochondria as an indicator for the response of photodynamic therapy,"J. Biomed. Opt. 9, 772–778 (2004).

[32] A. Mayevsky, G. G. Rogatsky, "Mitochondrial function in vivo evaluated by NADH fluorescence: from animal models to human studies," Am. J. Physiol Cell Ph. 292, C615–C640 (2007).

[33] K. D. V. Jayanth Kumar, Ganesan Singaravelu, "In vivo estimation of redox states with auto- fluorescence spectroscopy in oral submucous fibrosis patients: A Pilot Study," J. Indian Acad. Oral Med. Radiol. 24, 257–260 (2012).

[34] M. S. Islam, M. Honma, T. Nakabayashi, M. Kinjo, N. Ohta, "pH dependence of the fluorescence lifetime of FAD in solution and in cells," Int. J. Mol. Sci. 14, 1952–1963 (2013).

[35] J. V. Rocheleau, W. S. Head, D. W. Piston, "Quantitative NAD(P)H/flavoprotein autofluorescence imaging reveals metabolic mechanisms of pancreatic islet pyruvate response," J. Biol. Chem. 279, 31780–31787 (2004).

[36] A. V. Kuznetsov, J. Troppmair, R. Sucher, M. Hermann, V. Saks, R. Margreiter, "Mitochondrial subpopulations and heterogeneity revealed by confocal imaging: Possible physiological role " Biochim. Biophys. Acta. 1757, 686–691 (2006).

[37] R. Y. Tsien, "The green fluorescent protein," Annu. Rev. Biochem. 67, 509–544 (1998).